LifeMD, Inc. 8-K

What Happened

• On March 9, 2026, LifeMD, Inc. announced its financial results for the three months and full year ended December 31, 2025, and provided earnings guidance for 2026. The company furnished a press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2) with the Form 8-K. The investor presentation may be used in investor and analyst presentations and is available on LifeMD’s website.

Key Details

• Date filed: March 9, 2026 (Form 8-K).
• Results covered: quarter and year ended December 31, 2025.
• Guidance: company issued earnings guidance for 2026 (details in press release/presentation).
• Materials: Press release (Exhibit 99.1) and investor presentation (Exhibit 99.2) furnished with the filing; presentation available at https://lifemd.com.

Why It Matters

• Quarterly and full‑year results, plus 2026 guidance, are primary drivers of investor expectations for revenue, profitability and stock performance. Retail investors should read the press release and investor presentation for the actual revenue, earnings and guidance figures and compare them to prior results and market expectations. The presentation includes forward‑looking statements and should be considered alongside LifeMD’s SEC filings and risk disclosures.